文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

血浆肾素浓度动态变化预测心脏术后急性肾损伤

Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01
一句话结论心脏术后Δ-肾素升高与低血压、升压药使用延长及AKI风险增加相关,Δ-肾素对AKI预测优于术后单点肾素浓度。

这项单中心前瞻性观察研究纳入197例心脏手术患者,主要终点为术后72小时内AKI。基线肾素中位40.2 μU/ml,术后4小时51.3 μU/ml,Δ-肾素中位3.7 μU/ml。Δ-肾素升高者AKI发生率显著更高(43% vs 12.2%,P<0.001),且与更低平均动脉压、更长升压药使用时间及ICU/住院时间相关。Δ-肾素预测AKI的AUC为0.817(95%CI 0.747-0.887),显著优于术后肾素浓度(AUC 0.702,95%CI 0.610-0.793;P=0.007)。

要点

  • 心脏术后Δ-肾素升高者AKI发生率43%,显著高于Δ-肾素未升高者的12.2%(P<0.001)。
  • Δ-肾素预测AKI的AUC为0.817(95%CI 0.747-0.887),优于术后单点肾素AUC 0.702(95%CI 0.610-0.793;P=0.007)。
  • 高Δ-肾素与更低的平均动脉压、更长的升压药使用时间及更长的ICU和住院时间相关。
  • 基线肾素中位40.2 μU/ml(Q1-Q3 9.3-144.4),术后4小时中位51.3 μU/ml(Q1-Q3 19.1-167.0)。
  • Δ-肾素中位3.7 μU/ml(Q1-Q3 -22.7至50.9),为术后与术前肾素浓度之差。

适用人群与场景

  • 接受心脏手术的患者,单中心前瞻性观察研究纳入197例用于主要分析。

诊断标准与关键阈值

  • 主要终点为心脏手术后72小时内发生急性肾损伤(AKI)。
  • Δ-肾素定义为术后与术前肾素浓度之差,原文未给出用于诊断或分层的具体界值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 心脏术后Δ-肾素升高者AKI发生率43%,且与更低平均动脉压、更长升压药使用时间相关,提示需关注心血管不稳定和AKI风险。
  • 原文未给出基于Δ-肾素的具体干预措施或处理阈值。

研究设计与关键结果

  • 研究类型为单中心、前瞻性、观察性研究,197例心脏手术患者纳入主要分析。
  • 主要终点术后72小时内AKI:Δ-肾素升高者AKI发生率43%,显著高于Δ-肾素未升高者的12.2%(P<0.001)。
  • Δ-肾素预测AKI的AUC为0.817(95%CI 0.747-0.887),显著大于术后肾素浓度的AUC 0.702(95%CI 0.610-0.793;P=0.007)。
  • 高Δ-肾素与显著更低的平均动脉压、更长升压药使用时间及更长ICU和住院时间相关。
  • 基线肾素中位40.2 μU/ml(Q1-Q3 9.3-144.4),术后4小时中位51.3 μU/ml(Q1-Q3 19.1-167.0),Δ-肾素中位3.7 μU/ml(Q1-Q3 -22.7至50.9)。

证据类型、等级与局限

  • 证据类型为单中心、前瞻性、观察性研究。
  • 局限包括单中心、观察性设计,样本量197例,原文未提及盲法或外部验证。

对床旁实践的改变

  • 原文提示Δ-肾素可用于识别心脏术后心血管不稳定和AKI高风险患者,以期及时干预改善结局;但原文未给出具体干预措施或阈值,尚不能直接改变床旁处置流程。
  • Δ-肾素预测AKI优于术后单点肾素浓度,提示动态监测肾素变化可能比单次术后值更有价值。
  • 适用人群为心脏手术患者,原文未提及不适用人群;常见陷阱为将观察性关联误作因果或决策阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Rationale: The renin-angiotensin-aldosterone system is a major pathway in regulating blood pressure, glomerular filtration, and fluid homeostasis. During inflammatory diseases, generation of angiotensin II might be disturbed, leading to increased renin concentrations. Cardiac surgery and the use of cardiopulmonary bypass both induce inflammatory response and cardiovascular instability, which can contribute to acute kidney injury (AKI).Objectives: To investigate whether renin concentrations are associated with hypotension and AKI.Methods: This is a single-center, prospective, observational study among patients undergoing cardiac surgery.Measurements and Main Results: The primary endpoint was the occurrence of AKI within 72 hours after cardiac surgery. A total of 197 patients were available for the primary analysis. The median renin serum concentration was 40.2 μU/ml (quartile 1 [Q1]-Q3, 9.3-144.4) at baseline and 51.3 μU/ml (Q1-Q3, 19.1-167.0) 4 hours after cardiac surgery, whereas the difference between postoperation and preoperation concentrations (Δ-renin) was 3.7 μU/ml (Q1-Q3, -22.7 to 50.9). Patients with an elevated Δ-renin developed an AKI significantly more often (43% vs. 12.2%; P < 0.001). High Δ-renin after cardiac surgery was associated with a significantly lower mean arterial pressure, longer time on vasopressors, and longer length of ICU and hospital stay. The area under the curve (AUC) of Δ-renin for the prediction of AKI (AUC, 0.817; 95% confidence interval, 0.747-0.887) was significantly greater compared with the AUC of the postoperative renin concentrations (AUC, 0.702; 95% CI, 0.610-0.793; P = 0.007).Conclusions: Elevated renin concentrations were associated with cardiovascular instability and increased AKI after cardiac surgery. Elevated renin concentrations could be used to identify high-risk patients for cardiovascular instability and AKI who would benefit from timely intervention that could improve their outcomes.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Küllmar M, Saadat-Gilani K, Weiss R, et al. Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients. Am J Respir Crit Care Med. 2021. PMID: 33320784. doi:10.1164/rccm.202005-2050OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。